Do women in the Valencian Community accept self-sampling as a form of cervical cancer screening?
e202101023
Keywords:
Acceptance, Population screening, HPV, Self-sampling, Participation, Survey, Cervical cancer screening, Social inequalitiesAbstract
Background: The use of new devices such as the self-sampling for the determination of the Human Papilloma Virus (HPV), could facilitate the implementation of population screening programs and increase the participation of women. The objective of the study was to find out the women´s knowledge and attitudes towards cervical cancer screening as well as the acceptability of self-sampling.
Methods: Analytical cross-sectional study by telephone survey carried out on a random sample of 389 women from 35 to 65 years of age. The women were asked about their attitudes and knowledge of the screening and preference for HPV determination by self-sampling or by a healthcare professional.
Results: 86.9% of the women preferred self-sampling as a screening method and 93.3% had undergone a previous cervical cytology. 51.4% of the women had a high level of knowledge about cervical cancer screening. Younger women (POR 9.26; 95% CI 1.04-24.38), higher level of education (POR 4.6; 95% CI: 1.92-11.00), and higher level of knowledge (POR 2.78; 95% CI: 1.69-9.29), presented higher preferences for the determination of HPV by self-sampling. The trend in age, educational level and knowledge was the same for the prevalence of previous cervical cytology.
Conclusions: The acceptance of self-testing as a method of cervical cancer screening is high among women. Efforts should be made to raise awareness among women to reduce possible inequalities in access and to encourage informed participation.
Downloads
References
Council of the European Union. Council recommendation of 2 December 2003 of cancer screening (2003/873/EC). Off.J.Union 327,34-38; 2003.
IARC. Cervix Cancer Screening. Vol. 10, Handbooks of Cancer Prevention. 2005.
Sanidad MDE, Social CYB. Boletín oficial del estado. 2019;43018–28.
Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N et al. European guidelines for quality assurance in cervical cancer screening. Second edition-summary document. Vol. 21, Annals of Oncology. 2010. 448–458 p.
Chao YS, Clark M, Ford C. HPV Self-Sampling for Primary Cervical Cancer Screening: A Review of Diagnostic Test Accuracy and Clinical Evidence [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.
Yeh PT, Kennedy CE, De Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: A systematic review and meta-Analysis. BMJ Glob Heal. 2019;4(3).
Madzima TR, Vahabi M, Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-To-reach women. Can Fam Physician. 2017;63(8):597–601.
Polman NJ, de Haan Y, Veldhuijzen NJ, Heideman DAM, de Vet HCW, Meijer CJLM et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med (Baltim). 2019;125:5–11.
Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017 Feb 1;93(1):56 LP – 61.
Ondryášová H, Koudeláková V, Drábek J, Vaněk P, Slavkovský R, Hajdúch M. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study]. Ces Gynekol. 2015 Dec;80(6):436–443.
Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses. BMJ. 2018;363.
Tamalet C, Halfon P, Retraite L Le, Grob A, Leandri FX, Heid P et al. Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France. J Clin Virol. 2016;78:102–107.
Morgan K, Azzani M, Khaing SL, Wong YL, Su TT. Acceptability of Women Self-Sampling versus Clinician-Collected Samples for HPV DNA Testing: A Systematic Review. J Low Genit Tract Dis. 2019;23(3).
Silva J, Cerqueira F, Medeiros R. Acceptability of self-sampling in Portuguese women: The good, the bad or the ugly? Sex Health. 2017;14(3):298–300.
Caleia AI, Pires C, Pereira J F, Pinto-Ribeiro F, Longatto-Filho A. Self-Sampling as a Plausible Alternative to Screen Cervical Cancer Precursor Lesions in a Population with Low Adherence to Screening: A Systematic Review. Acta Cytol. 2020 Jan 20;1–12.
Chatzistamatiou K, Vrekoussis T, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, Pasentsis K et al. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening. J Womens Health (Larchmt). 2020 Nov;29(11):1447–1456.
Mao C, Kulasingam SL, Whitham HK, Hawes SE, Lin J, Kiviat NB. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening. J Womens Health (Larchmt). 2017 Jun;26(6):609–615.
Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J cancer. 2013 Dec;133(11):2681–2687.
Piana L, Leandri F-X, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône]. Bull Cancer. 2011 Jul;98(7):723–731.
Gök M, van Kemenade FJ, Heideman DAM, Berkhof J, Rozendaal L, Spruyt JWM et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J cancer. 2012 Mar;130(5):1128–1135.
Cobo-Cuenca AI, Rodríguez-Borrego M-A, Hidalgo-Lópezosa P, Rodríguez-Muñoz PM, Martins M, Carmona-Torres JM. Prevalence and determinants in cytology testing for cervical cancer screening in Spain (2006-14). Eur J Public Health. 2018 Jun;28(3):410–415.
Rossi PG, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104:248–254.
Conselleria Sanitat Universal i Salut Pública. IV Plan de Salud de la Comunitat Valenciana. 2016-2020.
Musa J, Achenbach CJ, O’Dwyer LC, Evans CT, McHugh M, Hou L et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017;12(9):1–28.
Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014 Jun;14:596.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 María Besó Delgado, Josefa Ibáñez Cabanell, Ana Molina-Barceló, Óscar Zurriaga Llorens, Dolores Salas Trejo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
